Purfalcamine

• CAT Number: I035223
• CAS Number: 1038620-68-6
• Molecular Formula: C29H33FN8O
• Molecular Weight: 528.63
• Purity: 98%
• Synonyms: Purfalcamine
• Target: Parasite
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Store at -20°C
• IUPAC Name: [4-[[2-[(4-aminocyclohexyl)amino]-9-(3-fluorophenyl)purin-6-yl]amino]phenyl]-piperidin-1-ylmethanone
• InChI: InChI=1S/C29H33FN8O/c30-20-5-4-6-24(17-20)38-18-32-25-26(35-29(36-27(25)38)34-23-13-9-21(31)10-14-23)33-22-11-7-19(8-12-22)28(39)37-15-2-1-3-16-37/h4-8,11-12,17-18,21,23H,1-3,9-10,13-16,31H2,(H2,33,34,35,36)
• InChIKey: KRCOMOOXOZSNAJ-UHFFFAOYSA-N
• SMILES: C1CCN(CC1)C(=O)C2=CC=C(C=C2)NC3=C4C(=NC(=N3)NC5CCC(CC5)N)N(C=N4)C6=CC(=CC=C6)F

Purfalcamine（Cat No.:I035223）is a potent, selective inhibitor of the enzyme cysteine protease cathepsin S, which plays a key role in the processing of antigens and regulation of immune responses. By inhibiting cathepsin S, Purfalcamine has the potential to modulate immune activity, making it a promising candidate in the treatment of autoimmune diseases, inflammation, and cancer immunotherapy. This compound’s selectivity for cathepsin S enhances its therapeutic potential, offering a targeted approach to disrupt pathological immune processes while minimizing off-target effects. Purfalcamine is a valuable tool for drug discovery and development in immunological disorders.